Scholarly inquiries delineate a gradual ascent in the methylation gradations of DAPK, spanning from nontumorous epithelial regions in the environs of ESCC to intraepithelial neoplasia and advanced ESCC, demonstrating a notable correlation with P53 mutations. The gene discussed is DAPK1; the disease is esophageal squamous cell carcinoma.